Serum creatine kinase and pyruvate kinase in Duchenne muscular dystrophy carrier detection
- PMID: 492209
- DOI: 10.1002/mus.880020503
Serum creatine kinase and pyruvate kinase in Duchenne muscular dystrophy carrier detection
Abstract
The incidence of elevated serum creatine kinase (CK) and pyruvate kinase (PK) activities was compared in 20 definite carriers of Duchenne muscular dystrophy (DMD), 47 possible carriers, and 42 female controls. When adult age was not regarded as a variable, 70% of the definite carriers had elevated PK, 55% had elevated CK, and 75% had elevated PK or elevated CK or both, 38% of the possible carriers had elevated PK, 19% had elevated CK, and 40% had elevated PK or elevated CK or both. The detection efficiency of the CK test was influenced by the age of the subjects: the upper normal limit of serum CK in the adult controls was at the minimum between 21 and 35 years of age, and CK activity in some carriers declined from elevated to normal levels with increasing age. With these considerations, 70% of definite carriers had elevated CK and 80% had elevated PK and/or CK; 34% of the possible carriers had elevated CK and 43% had elevated PK and/or CK. On the basis of the PK and CK measurements, only 16 of 24 possible carrier mothers were likely to be DMD carriers, implying that the other 8 were non-carrier mothers of new mutant sons.
Similar articles
-
Evaluation of carrier detection rates for Duchenne and Becker muscular dystrophies using serum creatine-kinase (CK) and pyruvate-kinase (PK) through discriminant analysis.Am J Med Genet. 1986 Oct;25(2):219-30. doi: 10.1002/ajmg.1320250204. Am J Med Genet. 1986. PMID: 3777019
-
Clinical investigation in Duchenne dystrophy: V. Use of creatine kinase and pyruvate kinase in carrier detection.Muscle Nerve. 1985 Jan;8(1):60-7. doi: 10.1002/mus.880080111. Muscle Nerve. 1985. PMID: 4058458
-
Creatine-kinase and pyruvate-kinase activities in normal children: implications in Duchenne muscular dystrophy carrier detection.Am J Med Genet. 1985 Oct;22(2):255-62. doi: 10.1002/ajmg.1320220206. Am J Med Genet. 1985. PMID: 4050856
-
The enzymology of skeletal muscle disorders.Crit Rev Clin Lab Sci. 1984;20(2):153-90. doi: 10.3109/10408368409165773. Crit Rev Clin Lab Sci. 1984. PMID: 6373145 Review.
-
[Duchenne-type muscular dystrophy: problems, early diagnosis, early treatment (author's transl)].Klin Padiatr. 1978 Nov;190(6):531-9. Klin Padiatr. 1978. PMID: 362050 Review. German.
Cited by
-
Myoglobin is a sensitive marker of increased muscle membrane vulnerability.J Neurol. 1990 Jul;237(4):234-8. doi: 10.1007/BF00314625. J Neurol. 1990. PMID: 2391544
-
A method for the detection of carriers of Duchenne muscular dystrophy--a preliminary report.Am J Hum Genet. 1981 Nov;33(6):978-86. Am J Hum Genet. 1981. PMID: 7325161 Free PMC article.
-
Precurarisation in infants and children less than three years of age.Can J Anaesth. 1987 Jan;34(1):17-20. doi: 10.1007/BF03007676. Can J Anaesth. 1987. PMID: 3549028 Clinical Trial.
-
Results of blind testing a method to detect carriers of the Duchenne muscular dystrophy gene.Am J Hum Genet. 1984 Jul;36(4):926-30. Am J Hum Genet. 1984. PMID: 6475962 Free PMC article.
-
The female carrier of Duchenne muscular dystrophy.Br Med J (Clin Res Ed). 1982 May 15;284(6327):1423-4. doi: 10.1136/bmj.284.6327.1423. Br Med J (Clin Res Ed). 1982. PMID: 6805547 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials